share_log

Pharmesis Intl: REPL-Placements-Proposed Subscription of 4,100,000 New Ordinary Shares - Receipt of Approval In-Principle

Pharmesis Intl: REPL-Placements-Proposed Subscription of 4,100,000 New Ordinary Shares - Receipt of Approval In-Principle

中嘉国际:REPL-Placements-拟认购4,100,000新普通股-获得原则上批准
新加坡交易所 ·  06/04 07:08
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息